Tag: Dr Mal Eutick
Phebra partners with University of Wollongong to develop drug for leukemia, pancreatic cancer
Australian pharmaceutical firm Phebra and the University of Wollongong (UOW) have entered into a six-year collaboration agreement to carry out research and development (R&D) and trials of patented and targeted arsenic compounds for the treatment of acute myeloid leukemias and pancreatic cancer.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
